TY - JOUR
T1 - Heart failure admission across glomerular filtration rate categories in a community cohort of 125,053 individuals over 60 years of age
AU - Alcober-Morte, Laia
AU - Barrio-Ruiz, Carmen
AU - Parellada-Esquius, Neus
AU - Subirana, Isaac
AU - Comín-Colet, Josep
AU - Grau, Maria
AU - Dégano, Irene R.
AU - Cainzos-Achirica, Miguel
AU - Cunillera-Puértolas, Oriol
AU - Cobo-Guerrero, Sílvia
AU - Mestre-Ferrer, Jordi
AU - Pascual-Benito, Luisa
AU - Cerain-Herrero, M. Jesús
AU - Gil-Terrón, Neus
AU - Rodríguez-Latre, Luisa
AU - Tamayo-Ojeda, Carmen
AU - Salvador-González, Betlem
N1 - Publisher Copyright:
© 2019, The Japanese Society of Hypertension.
PY - 2019/12/1
Y1 - 2019/12/1
N2 - A reduced estimated glomerular filtration rate (eGFR) has been described as a predictor of heart failure (HF). However, the increased risk across eGFR categories has not been fully evaluated, which is especially relevant in older individuals in whom both the prevalence of HF and decreased eGFR are higher. Furthermore, this association has not been studied in Mediterranean populations, where coronary heart disease (CHD), a frequent cause of HF, has a low prevalence. We performed a retrospective cohort study using the electronic medical records from primary and hospital settings in northeastern Spain. We included 125,053 individuals ≥60 years old with the determination of creatinine and without diagnosis or previous admission due to HF. The eGFR was calculated according to the CKD-EPI formula and classified by clinical categories. The association between eGFR, as a continuous and categorical variable, and the risk of admission due to HF was assessed by Cox proportional risk analysis, considering death as a competitive risk. During a median follow-up of 38.8 months, 2,176 individuals (1.74%) were hospitalized due to HF. The unadjusted admission rates were 4.02, 13.0, 26.0, and 48.6 per 1000 person-years for eGFR > 60, 45–59, 30–44, and 15–29 ml/min/1.73 m2, respectively. The corresponding hazard ratios (95% confidence interval; reference eGFR 60–89) were 1.38 (95% CI 1.23–1.55), 2.02 (95% CI 1.76–2.32) and 3.46 (95% CI 2.78–4.31). In this Mediterranean community-based cohort of individuals ≥60 years old without previous HF, the risk of admission due to HF gradually increased with decreasing eGFR.
AB - A reduced estimated glomerular filtration rate (eGFR) has been described as a predictor of heart failure (HF). However, the increased risk across eGFR categories has not been fully evaluated, which is especially relevant in older individuals in whom both the prevalence of HF and decreased eGFR are higher. Furthermore, this association has not been studied in Mediterranean populations, where coronary heart disease (CHD), a frequent cause of HF, has a low prevalence. We performed a retrospective cohort study using the electronic medical records from primary and hospital settings in northeastern Spain. We included 125,053 individuals ≥60 years old with the determination of creatinine and without diagnosis or previous admission due to HF. The eGFR was calculated according to the CKD-EPI formula and classified by clinical categories. The association between eGFR, as a continuous and categorical variable, and the risk of admission due to HF was assessed by Cox proportional risk analysis, considering death as a competitive risk. During a median follow-up of 38.8 months, 2,176 individuals (1.74%) were hospitalized due to HF. The unadjusted admission rates were 4.02, 13.0, 26.0, and 48.6 per 1000 person-years for eGFR > 60, 45–59, 30–44, and 15–29 ml/min/1.73 m2, respectively. The corresponding hazard ratios (95% confidence interval; reference eGFR 60–89) were 1.38 (95% CI 1.23–1.55), 2.02 (95% CI 1.76–2.32) and 3.46 (95% CI 2.78–4.31). In this Mediterranean community-based cohort of individuals ≥60 years old without previous HF, the risk of admission due to HF gradually increased with decreasing eGFR.
KW - Glomerular filtration rate
KW - Heart failure
KW - Older adults
KW - Primary care
KW - Risk factor
UR - http://www.scopus.com/inward/record.url?scp=85072171750&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072171750&partnerID=8YFLogxK
U2 - 10.1038/s41440-019-0315-6
DO - 10.1038/s41440-019-0315-6
M3 - Article
C2 - 31477871
AN - SCOPUS:85072171750
SN - 0916-9636
VL - 42
SP - 2013
EP - 2020
JO - Hypertension Research
JF - Hypertension Research
IS - 12
ER -